With proper intervention, osteoporosis is a largely preventable sequela of menopause. Bisphosphonates (alendronate, etidronate, ibandronate, risedronate, and zoledronic acid) are the most useful pharmacologic intervention. Most of them prevent vertebral fractures, as do raloxifene and estrogen; however, raloxifene and estrogen have been shown to increase risk for thromboembolic events. Some bisphosphonates (alendronate, risedronate, and zoledronic acid) prevent hip and other nonvertebral fractures.
For more on osteoporosis as a sequela of menopause, read here.
Medscape © 2015
Cite this: Fast Five Quiz: Do You Know the Conditions Associated With Menopause and How Best to Treat Them? - Medscape - Jan 20, 2015.